NCT07134933

Brief Summary

The high incidence of breast cancer is increasing the need for oncologic breast surgery. The optimal acute postoperative pain management after breast surgery is not yet clear. The erector spinae plane block (ESPB) is a newer and may be potentially safer alternative other regional analgesia techniques. We will investigate the effectiveness of ESP for managing acute pain after breast cancer surgery. Patients will randomise to receive either ESP block (Group1)or no ESP block (Group II). The primary outcome is postoperative pain scores used Visual Analog Scale (VAS), and the secondary outcomes include intraoperative opioid consumption postoperative total opioid consumption and patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 25, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2019

Completed
6.3 years until next milestone

First Submitted

Initial submission to the registry

August 14, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2025

Completed
Last Updated

August 21, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 14, 2025

Last Update Submit

August 14, 2025

Conditions

Keywords

Erector spinae plane blockpatient satisfactionbreast surgerypostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Remifentanil Consumption

    The primary aim of our study was to compare perioperative remifentanil consumption between Group I patients who received a preoperative ESP block and Group II patients who underwent surgery without the block.

    From beginning of anesthesia to finished the surgery

Secondary Outcomes (3)

  • postoperative morphine consumption

    from the end of the surgery to 24 hours of postoperative

  • The VAS scores

    from the end of the surgery to 24 hours of postoperative

  • patient satisfaction

    at the 24th postoperative hour

Study Arms (2)

Group I

ACTIVE COMPARATOR

The group with ESP block was defined as Group 1. The ESP block was performed unilaterally in the direction of the surgery.

Procedure: ESP (erector spinae plane)block

Group II

NO INTERVENTION

The group without ESP block was defined as Group II.

Interventions

The ESP block was performed unilaterally in the direction of the surgery by the same anesthetist. Blocks were performed using an Esaote ultrasound device (Esaote My Lab 6 US machine, Florence, Italy), a multifrequency convex probe (1-8 MHz), and a 22-gauge, 50 mm facet needle (B. Braun Sonoplex, Melsungen, Germany). The block needle was placed at the level of the T4 spinal process using the in-plane approach, approximately 3 cm lateral to the T4 spinous process in the parasagittal plane. After visualizing the transverse process with the in-plane approach, the 50 mm facet needle (B. Braun Sonoplex, Melsungen, Germany) was inserted through the skin, and a test dose of 1 ml of 0.9% NaCl was injected between the fascia of the trapezius, rhomboid, and erector spinae muscles and the transverse vertebral process to confirm the location. A total of 20 ml of 0.5% bupivacaine was used as a local anesthetic.

Group I

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince patients were required to undergo breast surgery, only female gender was included in the study.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I-II
  • the patients who undergone unilateral surgery due to breast tumors

You may not qualify if:

  • obesity (body mass index\> 35 kg/m²)
  • infection at the needle entry site,
  • known allergy history to the medications to be used,
  • coagulopathy
  • a history of opioid use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İnonu University Medicine Faculty Turgut ozal Medical Center

Malatya, 44100, Turkey (Türkiye)

Location

Related Publications (1)

  • Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017 Jul 1;152(7):691-697. doi: 10.1001/jamasurg.2017.0898.

    PMID: 28564673BACKGROUND

MeSH Terms

Conditions

Patient Satisfaction

Interventions

Parapsychology

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Behavioral SciencesBehavioral Disciplines and Activities

Study Officials

  • Mukadder Sanli, Associate Professor

    Inonu University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 14, 2025

First Posted

August 21, 2025

Study Start

December 25, 2018

Primary Completion

March 1, 2019

Study Completion

April 20, 2019

Last Updated

August 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

We do not want our data to be used by others.

Locations